RCAN1 and Down syndrome: Furthermore, using transgenic mice trisomic for RCAN1 alone as well as genetically correcting RCAN1 levels in Down syndrome mice, we establish a causal link between increased RCAN1 dosage, impaired neurotrophin receptor trafficking and developmental abnormalities in the sympathetic nervous system in Down syndrome.